Global Precision Medicine Summit

March 2017



Hotel Riu Plaza Berlin

Martin-Luther-Straße 1, 10777

About Summit

This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on current challenges, best practice and the inside view of the future of Precision Medicine. We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in the Precision Medicine Public Health landscape.

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Precision Medicine
  • Translational Medicine
  • Innovative Medicine
  • Companion Diagnostics
  • Diagnostic Development 
  • Genetics 
  • Microbiome 
  • Digital Health
  • Personalized Medicine
  • Experimental Medicine
  • Stratified Medicine
  • Molecular Diagnostics
  • Biomarker (DNA, RNA, protein,  exosome-, microbiome-, glyco-, digital-markers)
  • Oncology 
  • Bioinformatics 

From Industries Including:

  • Pharmaceutical
  • Nutraceuticals
  • Clinical Research & Development
  • Venture Capital
  • Biotechnologies
  • Medical Devices & Diagnostic
  • Start-ups
  • Tech / Service Providers
Key Practical Learning Points of the Summit

Opportunities for Personalized Healthcare and insights from key industry players to leverage your business
Emerging applications / Recent developments in cutting-edge scientific knowledge, tools, methods, and technologies to enable Precision Medicine
Strategies to get new biomarkers – Driving Personalized Therapies to market faster, at lower cost, and successful adoption of a patient-centered healthcare ecosystem
Approaches to go beyond oncology, to discover the future of Precision Medicine and to accelerate the impact of personalized therapies
Andrew Fried MBA

Life Sciences Europe Director


Dr. Arndt Schmitz

Research Biobank & Senior Translational Assay Technology Expert

Bayer Pharma AG, Germany

Dr. François-Pierre Martin

Senior Project Leader and Senior PI, Nutrition and Metabolic Health

Nestlé Institute of Health Sciences SA, Switzerland

Dr. Jonathan Sheldon

Global VP, Healthcare Health Sciences Global Business Unit

Oracle, UK

Dr. Josef Straub

Associated Director Clinical Biomarkers & Companion Diagnostics R&D, Global Early Development

Merck KGaA, Germany

Dr. Oliver Chao

Head, Emerging Biomedical Sciences Strategy & Innovation

Sanofi, France

Sponsors and Partners